SARSIA DEVELOPMENT AS
Portfolio companies
Balter Medical AS
Handheld imaging device to assist real-time, non-invasive detection of skin cancer.
BerGenBio AS
Novel approach to drug target and drug candidate selection and validation. Service provider and proprietary drug discovery.
Blue Limit AS
Specialised feed for the vulnerable early development phases of fish and shellfish larvae.
eNovate AS - sold
Software to plan, execute and document training programs. Applications include fire squads, airport control, defense and schools.
EnSo AS
Electricity based approach to neutralise unwanted marine organisms in ballast water.
Epsis AS
Hardware and software solutions for integrated operations and expert collaboration. Facilitates real-time access to data and analytical tools.
NorDiag ASA - stocklisted.
Automated solutions for sample preparation of bacterial and human DNA from difficult biological samples.
Novel Diagnostics ASA
Holding company with two daughter entities. ScreenCancer offers cancer screening services to companies. PlasmAcute develops laboratory products for early antibody detection.
Pattern Recognition Systems AS - sold
Software and services for multivariate analysis of large datasets.
Thia Medica AS - Sold
Modified fatty acids with metabolic effects. Active ingredients for food/ feed supplements, nutraceuticals, pharma.
UniTargetingResearch AS
Products and services for high yield biopharmaceutical protein production in mammalian cell systems.